Palliative RT research in prostate cancer: understanding the past, anticipating the future.

K. Dennis,S. Morgan
2014-04-01
Oncology
Abstract:Moving forward, perhaps no recent development in the use of RT in metastatic prostate cancer has captured greater attention than the use of radium-223 in metastatic castration-resistant prostate cancer (mCRPC).
What problem does this paper attempt to address?